TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Medicamentum Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4
|
0
|
0 |
| Financial expenses |
2
|
2
|
1 |
| Earnings before taxes |
-1
|
-8
|
-7 |
| EBITDA |
1
|
-7
|
-6 |
| Total assets |
34
|
41
|
46 |
| Current assets |
8
|
14
|
24 |
| Current liabilities |
26
|
32
|
37 |
| Equity capital |
8
|
9
|
9 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
0
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
23.5%
|
22.0%
|
19.6% |
| Turnover per employee | 4 | 0 | |
| Profit as a percentage of turnover | -25.0% | ||
| Return on assets (ROA) |
2.9%
|
-14.6%
|
-13.0% |
| Current ratio |
30.8%
|
43.8%
|
64.9% |
| Return on equity (ROE) |
-12.5%
|
-88.9%
|
-77.8% |
| Change turnover |
4
|
0
|
-5 |
| Change turnover % |
4300%
|
-67%
|
-95% |
| Chg. No. of employees |
1
|
-1
|
0 |
| Chg. No. of employees % |
-100%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.